Cannabis Clinical Trials: CT-Cann2023 Congress kicks off in London

After the first edition in 2019, the 2nd International Congress of Cannabis Clinical Trials – CT-Cann2023, takes place on February 15 and 16, 2023 in London, at the Hilton London Canary Wharf, in South Quay Square, Marsh Wall. CT-Cann2023 will again bring together leading researchers, clinicians, industry professionals and other experts from around the world to discuss ways to improve current research strategies, new discoveries, practical dilemmas and future paths in this rapidly evolving field. Keynote speakers include Haggai Sharon, MD and President of the Israel Pain Association, Dedi Meiri, Technion Institute Israel, Mike Barnes, Medical Cannabis Clinicians Society and Cannabis Industry Council UK, as well as Staci Gruber , from the Faculty of Medicine at Harvard University, in the United States of America (USA), between many others. The congress is, once again, organized by BioEvents and Cannareporter is a Media partner.

“We will address, among other things, basic and clinical methodologies, new discoveries, regulatory and legal issues, pharmacological considerations, and technological advances. We will emphasize the practical implications for patients, researchers, prescribers and industry leaders”, says CT-Cann23 in a statement. The complete program of the two days of the event can be found here.

CT-Cann2023 will therefore inform attendees about the latest evidence and concepts regarding cannabinoid therapy, help prescribers implement best practices based on the clinical implications of current research and expert opinions, and serve as a platform for exchanging ideas and practices in cannabinoid medicine. It will bring clinicians, patients and industry leaders together in innovative and engaging discussions, giving rise to many debates and exchanges of ideas.

Os records costs between £430 and £700 and can be done at Congress official page.